
COVID‐19 infection in an infant with cystic fibrosis: A case report and possible therapeutic effect of hypertonic saline
Author(s) -
Seyedi Seyed Javad,
Sadeghi Hossein,
Kianifar HamidReza,
Hamedi Abdolkarim,
Saeidinia Amin
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5782
Subject(s) - medicine , hypertonic saline , cystic fibrosis , covid-19 , regimen , saline , pulmonary infection , pneumonia , intensive care medicine , gastroenterology , immunology , pediatrics , disease , infectious disease (medical specialty)
Pulmonary infections represent the major causes of morbidity and mortality in cystic fibrosis (CF). Here, we report a 3‐month‐old infant with pancreatic insufficient CF was hospitalized with positive RT‐PCR test for COVID‐19. He was treated successfully. Hypertonic saline can be hypothesized as a treatment regimen against COVID‐19 infection after further investigations.